Cargando…

Hematology and coagulation : a comprehensive review for board preparation, certification and clinical practice /

Detalles Bibliográficos
Clasificación:	Libro Electrónico
Autores principales:	Wahed, Amer (Autor), Dasgupta, Amitava, 1958- (Autor)
Formato:	Electrónico eBook
Idioma:	Inglés
Publicado:	Amsterdam : Elsevier Inc., [2015]
Temas:	Hematology. Coagulation. Blood > Coagulation. Hematologic Tests > methods Hematologic Diseases > diagnosis Blood Coagulation Hematology H�ematologie. Sang > Coagulation. HEALTH & FITNESS > Diseases > General. MEDICAL > Clinical Medicine. MEDICAL > Diseases. MEDICAL > Evidence-Based Medicine. MEDICAL > Internal Medicine. Blood > Coagulation Coagulation Internet Resources.
Acceso en línea:	Texto completo

Tabla de Contenidos:

7.2.2. Urine Electrophoresis
7.2.3. Immunofixation Studies
7.2.4. Capillary Zone Electrophoresis
7.2.5. Free Light-chain Assay
7.2.6. Paraprotein Interference in Clinical Laboratory Tests
7.3. Plasma Cell Neoplasm
7.3.1. Morphology of Plasma Cells in Myeloma
7.3.2. Immunophenotype of Neoplastic Plasma Cells
7.4. Cytogenetics in Myeloma Diagnosis
Key Points
References
8.1. Introduction
8.2. Flow Cytometry and Mature B Cell Lymphoid Neoplasms
8.2.1. B Cell Markers
8.3. Flow Cytometry and Mature T and Natural Killer Cell Lymphoid Neoplasms
8.3.1. Detection of Clonal or Restricted Populations of T and NK Celts
8.4. Plasma Cell Dyscrasias
8.5. Flow Cytometry and Acute Leukemia
8.5.1. Flow Cytometry and Subtypes of Acute Myeloid Leukemia
8.6. Flow Cytometry and Myelodysplastic Syndrome
8.7. Flow Cytometry and Hematogones
Key Points
References
9.1. Introduction
9.2. Cytogenetic Abnormalities in Chronic Myeloid Leukemia
9.3. Cytogenetic Abnormalities in Myelodysplastic Syndrome
9.4. Cytogenetic Abnormalities in Patients with Acute Myeloid Leukemia
9.5. Cytogenetic Abnormalities in Actute Lymphoblastic Leukemia
9.6. Cytogenetic Abnormalities in Multiple Myeloma
9.7. Cytogenetic Abnormalities in B and T Cell Lymphomas
9.7.1. CLL/SLL
9.7.2. Follicular Lymphoma
9.7.3. Mantle Cell Lymphoma
9.7.4. Marginal Zone Lymphoma
9.7.5. Diffuse Large B Cell Lymphoma
9.7.6. Burkitt Lymphoma
9.7.7. Anaplastic Large Cell Lymphoma
Key Points
References
10.1. Introduction
10.2. Reactive Lymphoid States
10.2.1. Viral Lymphadenopathy
10.2.2. Bacterial Infections and Lymphadenopathy
10.2.3. Toxoplasma gondii and Lymphadenopathy
10.2.4. Granulomatous Lymphadenopathy
10.2.5. Necrotizing Lymphadenopathy
10.2.6. Progressive Transformation of Germinal Centers
10.2.7. Regressive Changes in Germinal Centers
10.3. Specific Clinical Entities with Lymphadenopathy
10.3.1. Kikuchi-Fujimoto Disease
10.3.2. Kimura Disease
10.3.3. Kawasaki Disease
10.3.4. Dermatopathic Lymphadenitis
10.3.5. Lymphadenopathy in Autoimmune Diseases
10.3.6. Rosai-Dorfman Disease
10.3.7. Langerhans Cell Histiocytosis
10.3.8. Castleman Disease
Key Points
References
11.1. Introduction
11.2. Follicular Lymphoma
11.2.1. Immunophenotyping in Follicular Lymphoma
11.2.2. Genetics of Follicular Lymphoma
11.3. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
11.3.1. Immunophenotyping for CLL/SLL
11.4. B Cell Prolymphocytic Leukemia
11.5. Mantle Cell Lymphoma
11.6. Marginal Zone B Cell Lymphoma
11.6.1. MALT Lymphoma
11.6.2. Splenic Marginal Zone Lymphoma
11.6.3. Nodal Marginal Zone Lymphoma
11.7. Burkitt Lymphoma
11.8. Lymphoblastic Leukemia/Lymphoblastic Lymphoma
11.9. Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia
11.10. Diffuse Large B Cell Lymphoma
11.10.1. B Cell Lymphoma, Unclassifiable with Features Intermediate Between DLBCL and Burkitt Lymphoma (Gray Zone Lymphoma)
11.11. Hairy Cell Leukemia
11.11.1. Approach to the Diagnosis of Lymphoma
Key Points
References
12.1. Introduction
12.2. Nodal T Cell Lymphomas
12.2.1. Angioimmunoblastic T Cell Lymphoma
12.2.2. Peripheral T Cell Lymphoma
12.2.3. Anaplastic Large Cell Lymphoma
12.3. Extranodal NK/T Cell Lymphomas
12.3.1. Extranodal NK/T Cell Lymphoma, Nasal Type
12.3.2. Enteropathy-associated T Cell Lymphoma
12.3.3. Hepatosplenic T Cell Lymphoma
12.3.4. Subcutaneous Panniculitis-like T Cell Lymphoma
12.4. Cutaneous T Cell Lymphoma
12.4.1. Mycosis Fungoides
12.4.2. Sezary Syndrome
12.4.3. Primary Cutaneous CD30+ T Cell Lymphoproliferative Disease
12.5. Leukemia/disseminated
12.5.1. T Cell Prolymphocytic Leukemia
12.5.2. T Cell Large Granular Lymphocyte Leukemia
12.5.3. Chronic Lymphoproliferative Disorders of NK Cells
12.5.4. Aggressive NK Cell Leukemia
12.5.5. Adult T Cell Leukemia/Lymphoma
Key Points
References
13.1. Introduction
13.2. Overview of Hodgkin Lymphoma
13.3. Classification of Hodgkin Lymphoma
13.3.1. Nodular Lymphocyte Predominant Hodgkin Lymphoma
13.3.2. Classical Hodgkin Lymphoma
13.4. Immunostains for Diagnosis of Hodgkin Lymphoma
13.5. Staging of Hodgkin Lymphoma
Key Points
References
14.1. Introduction
14.2. Lymphoproliferative Disorders Associated with Immune Deficiency
14.2.1. Lymphoproliferative Disorders Associated with Primary Immune Deficiency
14.2.2. Lymphoproliferative Disorders Associated with HIV Infection.
Note continued: 14.2.3. Post-transplant Lymphoproliferative Disorders
14.3. Histiocytic and Dendritic Cell Neoplasms
14.3.1. Histiocytic Sarcoma
14.3.2. Dendritic Cell Neoplasms
Key Points
References
15.1. Introduction
15.2. Normal Hemostasis
15.2.1. Platelets and Platelet Events
15.3. Thrombocytopenia and Thrombocytopathia
15.3.1. Hereditary Thrombocytopenias
15.3.2. Idiopathic Thrombocytopenic Purpura
15.3.3. Heparin-induced Thrombocytopenia
15.4. Tests for Platelet Function
15.4.1. Thromboelastography
15.4.2. Platelet Mapping
15.5. Secondary Hemostasis
15.6. Tests for Secondary Hemostasis
15.6.1. Factor Assays
15.6.2. Von Willebrand Disease
15.6.3. Diagnosis of Various Types of Von Willebrand Disease
15.7. Antiplatelets and Anticoagulants
Key Points
References
16.1. Introduction
16.2. Thrombophilia: Inherited Versus Acquired
16.3. Factor V Leiden
16.3.1. Activated Protein C Resistance Test
16.4. Prothrombin Gene Mutation
16.5. Protein C Deficiency
16.6. Protein S Deficiency
16.6.1. Assays for Protein C and Protein S
16.7. Antithrombin III Deficiency
16.8. Hyperhomocysteinemia
16.9. Increased Factor VIII Activity
16.10. Acquired Causes of Thrombophilia
16.10.1. Lupus Anticoagulant and Anticardiolipin Antibodies
Key Points
References
17.1. Introduction
17.2. Errors in Routine Hematology Testing
17.2.1. Errors in Hemoglobin Measurement and RBC Count
17.2.2. Errors in MCV and Related Measurements
17.2.3. Errors in WBC Counts and WBC Differential Counts
17.2.4. Errors in Platelet Count
17.3. Errors in Specific Hematology Testing
17.3.1. Cold Agglutinins
17.3.2. Cryoglobulins
17.3.3. Pseudothrombocytopenia
17.3.4. Spurious Leukocytosis
17.3.5. False-positive Osmotic Fragility Test
17.4. Errors in Coagulation Testing
17.4.1. Errors in PT and aPTT Measurements
17.4.2. Errors in Thrombin Time Measurement
17.4.3. Platelet Aggregation Testing with Lipemic, Hemolyzed, or Thrombocytopenic Samples
17.4.4. Challenges in Anticoagulants and Lupus Anticoagulant Tests
Key Points
References.

Hematology and coagulation : a comprehensive review for board preparation, certification and clinical practice /

Ejemplares similares